Inspire Medical Systems, Inc. (NYSE:INSP) Q2 2022 Results Conference Call August 2, 2022 5:00 PM ET Company Participants Megan Rowekamp - Investor Relations Tim Herbert - President and Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Larry Biegelsen - Wells Fargo Robbie Marcus - JP Morgan Travis Steed - Bank of America Rich Newitter - Truist Jonathan Block - Stifel Amit Hazan - Goldman Sachs Chris Pasquale - Nephron Research Adam Maeder - Piper Sandler Michael Pol ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Inspire M ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q1 2022 Results Conference Call May 3, 2022 5:00 PM ET Company Participants Megan Rowekamp - Investor Relations Timothy Herbert - President and Chief Executive Officer Richard Buchholz - Chief Financial Officer Conference Call Participants Travis Steed - BofA Securities Robert Marcus - JPMorgan Chase Philip Coover - Goldman Sachs Group Danielle Antalffy - SVB Leerink Richard Newitter - Truist Securities Jonathan Block - Stifel, Nicolaus & Company Lei Huang - Wells ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Inspire Me ...

Sleep Apnea Innovation 1 Inspire Medical Systems, Inc. February 2022 NYSE: INSP Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forwardlooking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' '' ...

Sleep Apnea Innovation 1 Inspire Medical Systems, Inc. February 2022 NYSE: INSP Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forwardlooking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' '' ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 Inspire Medical Systems, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdi ...

Inspire Medical Systems, Inc. (NYSE:INSP) Q3 2021 Earnings Conference Call November 2, 2021 5:00 PM ET Company Participants Megan Rowekamp - Director of Financial Reporting Tim Herbert - President & Chief Executive Officer Rick Buchholz - Chief Financial Officer Conference Call Participants Jon Block - Stifel Danielle Antalffy - SVB Leerink Chris Pasquale - Guggenheim Robbie Marcus - JPMorgan Larry Biegelsen - Wells Fargo Adam Maeder - Piper Sandler Michael Polark - Baird Ravi Misra - Berenberg Capital Sura ...

Table of Contents For the quarterly period ended September 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38468 ______________________________ Inspire Medical Systems, Inc. UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 ______________________________ FORM 10-Q ________________________________ (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITI ...

Sleep Apnea Innovation 1 Inspire Medical Systems, Inc. August 2021 NYSE: INSP Disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts are forwardlooking statements. In some cases, you can identify forward-looking statements by terms such as ''may,'' ''will,'' ''should,'' ''expect,'' ''plan,'' ''anticipate,'' ''could,'' "future," "outlook," ''intend,'' ''target,'' ''pr ...